BioSig Technologies prices $15 million public offering at $3.90 per share

BioSig Technologies Inc. (NASDAQ: BSGM) announced the pricing of its underwritten public offering of 3,852,149 shares of common stock at $3.90 per share. The offering is expected to close on or around August 15, 2025, subject to customary closing conditions.

The company expects gross proceeds of approximately $15 million before deducting underwriter discounts, commissions and other offering expenses. BioSig stated it intends to use the net proceeds to purchase gold bullion in accordance with its investment policy, for working capital and general corporate purposes.

Clear Street and Needham & Company are serving as joint book-running managers for the offering. The offering is being conducted under a shelf registration statement on Form S-3 that was declared effective by the Securities and Exchange Commission on December 17, 2024.

BioSig recently merged with Streamex Exchange Corporation, a company that focuses on real-world asset and gold tokenization. The merged entity operates in the medical device technology sector with its PURE EP Platform for electrophysiology procedures.

The securities are being offered through a written prospectus that forms part of the effective registration statement. Copies of the final prospectus supplement and accompanying base prospectus will be available from the SEC and the underwriters.

You May Also Be Interested In

• DeFi Development Corp. plans $20M preferred stock offering
• Ranger Energy to buy Step Energy's U.S. coiled tubing assets for $27.5M
• Metallus CEO Michael Williams to retire; Kris Westbrooks named successor